Vilacto Bio
Manufacturing · Denmark · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Fabriksvej 48, Næstved, Zealand, 4700, D...Website
www.vilactobio.comRevenue
<$5 MillionIndustry
About Vilacto Bio
Is Vilacto Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Vilacto Bio had a recent Job posting/layoffs
Check out if Vilacto Bio is spiking on competitors!
Product Launch: Get notified when Vilacto Bio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Vilacto Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Vilacto Bio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Vilacto Bio has new funding data
Earning: See what the market has to say on Vilacto Bio recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Vilacto Bio
Recommended Actions
Find VP level buyers at Vilacto Bio
Find 3 more new buyers
Company Profile Activity
Activity Insights
Vilacto Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vilacto Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vilacto Bio.
Vilacto Bio Tech Stack
A closer look at the technologies used by Vilacto Bio
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vilacto Bio
Vilacto Bio specializes in the development of innovative immunotherapy and vaccine treatments utilizing their proprietary nanoparticle compound, LACTOACTIVE iTHER. Their products, which include skincare therapies based on bovine colostrum, aim to enhance immune responses and treat a variety of diseases such as cancer, psoriasis, and immunodeficienc... Read More